EORTC-related new drug discovery and development ...

Pamm eortc. Archivio estrazioni del lotto – settembre 1954 – vinco al lotto cerca nell’archivio storico del lotto le estrazioni settembre 1954 tramite il filtri anno e mese, sarà possibile in pochi click essere informati su tutte le estrazioni passate e di sapere quali 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002 napoli, 29, 3, 10, 55, 82 bari, 1, 76, 33 ... of the EORTC as a whole. PAMM merged with Preclinical Therapeutics Models Group (PTMG) in 2000 and with the Screening and Pharmacology Group (SPG) in 2003.The latter group continued as the Drug Discovery Committee within PAMM. The groups have always been involved in the development of anticancer agents, evolving from platinum analogs, anthracyclines, nitrosoureas, antifolates in the 1980’s ... PAMM – EORTC group . Personalized Health ... Oxnard GR, et al. Clin Cancer Res. 2011;17:1616-1622. Ohashi K, et al. Proc Nat Acad Sci USA. 2012;109:E2127-E2133. Takezawa K, et al. Cancer Discov. 2012;2:922-933. HER2 amplification (12%)+ BRAF mutation (1%)+ Mechanism of Acquired Resistance to EGFR TKIs PIK3CA (5%) SCLC transformation (14%) Re-biopsy . First-line Treatment With EGFR TKIs vs ... EORTC, Unicancer, INCA, Groupes coopératifs Francais JY Blay Pdt GSF-GETO/ Netsarc Dir. EuroSARC ( FP7 278472) Dir LYRIC DG Centre Léon Bérard . EORTC . 3 A brief history of the EORTC 1962 Creation of a European Group to fight cancer (GECA) 1965 European Journal of Cancer 1968 GECA becomes EORTC 1972 NCI liaison office in Brussels / EORTC-NCI meeting 1974 EORTC Data Center (now Headquarters ... PAMM is the principal pre-clinical group of the European Organisation for the Research and Treatment of Cancer (EORTC). It focuses on all aspects of anticancer drug action and development.

[index] [13894] [579] [5809] [6501] [12543] [14163] [1737] [9004] [15078] [7062]

#

test2